Status:
COMPLETED
Non-pharmacological Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation
Lead Sponsor:
National Research Center for Preventive Medicine
Collaborating Sponsors:
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
National Research Center of Surgery, Russia
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Left atrial appendage (LAA) occlude devices are used for over ten years. According to current data efficiency and safety of this approach at least comparable with pharmacological prevention of stroke ...
Eligibility Criteria
Inclusion
- Patient with paroxysmal/persistent/permanent atrial fibrillation
- CHA2DS2VASc score ≥2 for male and ≥3 for female
- Without contraindications to anticoagulation therapy
Exclusion
- LAA thrombosis
- mechanical prosthetic heart valve
- moderate or severe mitral valve stenosis
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03867227
Start Date
December 1 2018
End Date
December 1 2022
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
. National Research Center for Preventive Medicine of the Ministry of Health
Moscow, Russia, 101990